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INTRODUCTION
Natural products from plants are important sources of new 
drugs.[1] The genus Piper (胡椒 Hú Jiāo) (Piperaceae), which 
contains approximately 2000 plant species distributed mainly in 
tropical areas,[2] is a potential source of drugs based on the use of 
some Piper species in traditional medicine. For example, nearly 30 
out of 60 indigenous Chinese Piper species are used medically.[3‑8] 
Our recent ethnobotanical and medicinal chemistry research fo‑
cused on Piper plants led to the discovery of cytotoxic amides from 
Piper boehmeriifolium Wall.,[8‑11] an anticancer medicine used in 
India.[12] In China, Piper plants are also used in some formulae to 
treat cancers.[13,14] The present paper reviews the traditional uses 
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ABSTRACT
The ethnomedical uses of Piper (胡椒 Hú Jiāo) plants as anticancer agents, in vitro cytotoxic activity of both extracts and compounds 
from Piper plants, and in vivo antitumor activity and mechanism of action of selected compounds are reviewed in the present paper. 
The genus Piper (Piperaceae) contains approximately 2000 species, of which 10 species have been used in traditional medicines to 
treat cancer or cancer‑like symptoms. Studies have shown that 35 extracts from 24 Piper species and 32 compounds from Piper plants 
possess cytotoxic activity. Amide alkaloids account for 53% of the major active principles. Among them, piplartine (piperlongumine) 
shows the most promise, being toxic to dozens of cancer cell lines and having excellent in vivo activity. It is worthwhile to conduct 
further anticancer studies both in vitro and in vivo on Piper plants and their active principles.
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and scientific evidence for Piper natural products as anticancer 
agents. We reviewed the scientific articles that were published 
between 1970 and 2013 from Web of Science, SciFinder, and 
Google Scholar. We used the following search terms: Piperaceae, 
Piper, anticancer, antitumor, cytotoxicity, and ethnobotany. No 
restrictions regarding the language of publication were imposed, 
but most of the relevant studies were published in English and 
Chinese. Both plant extracts and compounds were found to show 
good in vitro cytotoxic activity with concentration giving 50% in‑
hibition (IC
50
) values less than 30 μg/ml and 4 μg/ml, respectively, 
and some compounds showed significant in vivo antitumor activity 
with 50% inhibition of tumor growth at concentrations less than 
15 mg/kg body weight in mice.[15]
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PIPER PLANTS WITH TRADITIONAL 
ANTICANCER APPLICATION
In the literature, 10 Piper (胡椒 Hú Jiāo) species have been 
reported to treat cancer or cancer‑like symptoms, as summarized 
in Table 1.
In Mexico, Piper aduncum L. is traditionally used to treat uro‑
logical problems, dermatological conditions, and skin tumors.[15] 
Dichloromethane extracts of P. aduncum leaf were marginally 
cytotoxic to glioma (SF‑268), human large cell lung carcino‑
ma (H‑460), and human breast carcinoma (MCF‑7) cell lines with 
IC
50
 values of 23, 25, and 27 μg/ml, respectively [Table 2].[16] 
Piperaduncin A [27 in Figure 1] a dihydrochalcone from this plant, 
showed growth inhibitory activity against human nasopharynx 
carcinoma (KB) cells (IC
50
 = 2.3 μg/ml) [Table 3].[17]
In the Ayurvedic system of Indian medicine, the roots of 
P. boehmeriifolium Wall. and Piper sylvaticum Roxb. are used for 
their laxative, anthelmintic, and carminative properties, as well as 
to treat bronchitis, diseases of the spleen, and tumors.[12] Recently, 
a cytotoxic amide alkaloid, 1‑[(9E)‑10‑(3,4‑methylenedioxyphe‑
nyl)‑ 9‑decenoyl] pyrrolidine [7 in Figure 2], was isolated from the 
whole plant of P. boehmeriifolium. This compound exhibited an 
IC
50
 of 2.7 μg/ml against human cervical carcinoma human cervix 
adenocarcinoma (HeLa) cells [Table 3].[11] The amide alkaloid 
piplartine [1 in Figure 2, Tables 3 and 4] might be responsible for 
the anticancer effect of P. sylvaticum.[18]
Piper capense L.f. is reported to treat cancer in Cameroon; 
however, details about its ethnomedical uses are not in‑
cluded in the literature references.[19,20] Methanolic extracts 
of the seed are cytotoxic toward many tumor cell lines, 
Table 1. List of Piper plants used traditionally against cancer or 
cancer‑like symptoms
Latin name Part used Country Use Ref.
P. aduncum L. Unknown Mexico Skin tumors [15,17]
P. boehmeriifolium 
Wall.
Root India Tumor [11,12]
P. capense L.f. Unknown Cameroon Cancer [19,20]
P. cubeba L. Seeds Morocco Cancer [23]
P. gibbilimbum 
C.DC.
The juice 
from the 
heated bark
Papua 
New 
Guinea
Cancer [27,28]
P. guineense 
Schum and Thonn
Seed Nigeria Cancer [29]
Unknown Cameroon Cancer [20]
P. longum L. Leaf Cook 
Islands
Breast cancer [30]
Unknown India Tumor [18]
P. nigum L. Root Thailand Abdominal 
tumors
[33]
Fruit China Respiratory or 
gastric cancers
[13,14]
P. sylvaticum 
Roxb.
Root India Tumor [18,12]
Piper sp. Leaf Bolivia Cancer of the 
uterus
[35]
Figure 1. Cytotoxic non‑alkaloid constituents from Piper plants
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including human leukemic lymphoblast (CCRF‑CEM; 
IC
50
 = 7.03 μg/ml), human acute T‑lymphoblastic leukemia (CEM/
ADR5000; IC
50
 = 6.56 μg/ml), human pancreatic adenocarcino‑
ma (Mia PaCa2; IC
50
 = 8.92 μg/ml), p53‑expressing human colon cancer 
cell (HCT116 p53+/+; IC
50
 = 4.64 μg/ml), p53‑knockout human colon 
cancer cell (HCT116 p53−/−; IC
50
 = 4.62 μg/ml), human hepatocarcino‑
ma (Hep‑G2; IC
50
 = 16.07 μg/ml), human myeloid leukemia (HL‑60; 
IC
50
 = 8.16 μg/ml), anthracycline‑resistant HL‑60 (HL‑60AR; 
IC
50
 = 11.22 μg/ml), human breast carcinoma (MDA‑MB‑231; 
IC
50
 = 4.17 μg/ml), MDA‑MB‑231BCRP (IC
50
 = 19.45 μg/ml), hu‑
man malignant glioblastoma (U87MG; IC
50
 = 13.48 μg/ml), EGFR‑
vIII expressing glioma cells (U87MGΔEGFR; IC
50
 = 7.44 μg/ml), 
etc.[19,20] Piperine [6 in Figure 2 and Table 3] might be an active 
constituent.[21,22]
A recent ethnopharmacological study in Morocco calculated 
the percent importance of 14 plants selected by 100 herbalists for 
significance against cancer. Piper cubeba (蓽澄茄 Bì Chéng Qié) 
was one of the most important plants against cancer.[23] Lignans, 
such as (‑)‑cubebin, are the major constituents of P. cubeba.[24] 
Research results show that the P. cubeba extract (P9605) and the 
synthetic lignan cubebin might have potential therapeutic use 
against prostate cancer growth by targeting multiple aspects of 
the androgen‑signaling pathway.[25,26]
In Papua New Guinea, a patient with suspected cancer or 
other internal sores drinks the juice squeezed from heated bark of 
Piper gibbilimbum C.DC. with traditional ash salt.[27] Gibbilimbols 
D (IC
50
 = 2.1 μg/ml) [19 in Table 3] and B (IC
50
 = 3.9 μg/ml) [20 
in Table 3] from this plant are cytotoxic toward KB cells.[28]
The seed of the Nigerian plant Piper guineense Schum and Thonn 
reportedly possesses anticancer properties.[29] The plant is also reported 
to treat cancer in Cameroon.[20] A methanolic extract of its seed was cy‑
totoxic against leukemia CEM/ADR5000 cells (IC
50
 = 8.20 μg/ml).[20] 
However, the active constituents remain unclear.
Piper longum L. (syn. Piper latifolium Forst.) is a well‑known 
tropical food and medicinal plant. In traditional medical practice in 
the Cook Islands, 12 leaves of this plant and a similar number of 
those of Thespesia populnea (L.) Soland (Malvaceae) are pounded 
in a wooden bowl with little water and the solution is washed on the 
chest of a person with suspected breast cancer.[30] P. longum is also 
used to treat tumors in Indian Ayurvedic medicine. Piplartine,[18] 
cepharadione A (15), and piperolactams A (16) and B (17) are the 
active principles.[31,32]
Figure 2. Cytotoxic amide alkaloids from Piper plants
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In Thailand, the root of Piper nigrum L. (black pepper plant), 
in the form of ghee, powders, enemas, and balms, is applied to 
abdominal tumors. The plant can also be used to treat abdominal 
fullness, adenitis, cancer, cholera, cold, colic, kidney stone, and 
headache.[33] Black pepper (黑胡椒 Hēi Hú Jiāo) is used in some 
formulae to treat respiratory or gastric cancers in China.[13,14] 
Piperine might be the major active principle from P. nigrum.[22,34]
In Bolivia, a reported Piper species known as Tudhar is used 
to treat uterine cancer.[35] However, the scientific name of the plant 
was not confirmed.
EXTRACTS FROM PIPER PLANTS WITH 
CYTOTOXIC ACTIVITY IN VITRO
Many crude extracts from Piper (胡椒 Hú Jiāo) plants have 
been evaluated for in vitro cytotoxicity based on ethnomedical 
knowledge, chemotaxonomic information, or random screen‑
ing. Among them, 35 extracts of 24 Piper species have shown 
inhibitory activity (IC
50
 < 30 μg/ml) against at least one tumor 
cell line [Table 2]. Extracts from P. aduncum L., Piper bar-
batum Kunth, Piper fragile Benth., Piper jacquemontianum 
Kunth, and Piper pellucidum L. showed the highest potential 
against at least one tumor cell line, with an IC
50
 value less 
than 4 μg/ml.[16,36]
COMPOUNDS FROM PIPER PLANTS WITH 
CYTOTOXIC ACTIVITY IN VITRO
Chemical constituents of Piper (胡椒 Hú Jiāo) plants mainly 
include amide alkaloids, phenylpropanoids, lignans, neolignans, 
Table 2. Cytotoxic crude extracts from Piper plants
Latin name Part used Extract Tumor cell line (IC50 μg/ml) Ref.
Piper acutifolium Ruiz and Pav. Leaf CH2Cl2 H‑460 (25), SF‑268 (27) [16]
P. aduncum L. Leaf CH2Cl2 KB (12) [17]
Leaf CH2Cl2 MCF‑7 (27), H‑460 (25), SF‑268 (23) [16]
Leaf EtOH HeLa (3.91) [36]
P. barbatum Kunth Aerial part EtOH MCF‑7 (3.3), H‑460 (3.7), SF‑268 (3.9) [16]
Leaf EtOH MCF‑7 (1.4), H‑460 (1.5), SF‑268 (1.5) [16]
Fruit EtOH MCF‑7 (1.75), H‑460 (2.05), SF‑268 (1.95) [16]
Piper betle L. Leaf EtOH HeLa (7.13) [36]
P. capense L.f. Seed MeOH CCRF‑CEM (7.03), CEM/ADR5000 (6.56), Mia PaCa2 (8.92) [20]
Seed MeOH CCRF‑CEM (6.95), HCT116 p53+/+ (4.64), HCT116 
p53−/− (4.62), HepG2 (16.07), HL‑60 (8.16), HL‑60AR (11.22), 
MDA‑MB‑231 (4.17), MDA‑MB‑231/BCRP (19.45), 
U87MG (13.48), U87MGΔEGFR (7.44)
[19]
Piper chaba L. Fruit EtOH HEp‑2 (18.93) [37]
Piper elongatum Vahl Leaf CH2Cl2 MCF‑7 (15), H‑460 (13), SF‑268 (13) [16]
P. fragile Benth. Leaf EtOH HeLa (2.93) [36]
Piper glabratum Kunth Leaf CH2Cl2 MCF‑7 (8), H‑460 (5.9), SF‑268 (6.4) [16]
P. guineense Schum and Thonn Seed MeOH CEM/ADR5000 (8.20) [20]
Piper heterophyllum Ruiz and Pav. Leaf CH2Cl2 MCF‑7 (29), H‑460 (26), SF‑268 (22) [16]
Piper hispidum Sw. Leaf CH2Cl2 MCF‑7 (17), H‑460 (14), SF‑268 (16) [16]
Piper holtonii C.DC. Root EtOH MCF‑7 (12), H‑460 (11), SF‑268 (13) [16]
Piper imperial C.DC. Leaf EtOH MCF‑7 (18.6) [38]
Flower EtOH MCF‑7 (24.5) [38]
P. jacquemontianum Kunth Herb EtOH MCF‑7 (3.9), H‑460 (4.9), SF‑268 (4.6) [16]
Aerial part EtOH HeLa (8) [39]
Piper longestylosum C.DC. Leaf CH2Cl2 MCF‑7 (27), H‑460 (24), SF‑268 (24) [16]
P. methysticum G. Forst. Root Unknown* DU145 (5.4), C4‑2B (7), LNCaP (6.5), PC3 (5.3), WPMY‑1 (15) [40]
P. nigrum L. Root CHCl
3
HL‑60 (9.8) [41]
Root PE HL‑60 (11.2) [41]
Seed EtOH HeLa (19) [42]
P. pellucidum L. Leaf EtOH HeLa (2.85) [36]
Piper pilirameum C.DC. Leaf CH2Cl2 MCF‑7 (17), H‑460 (14), SF‑268 (15) [16]
Piper rusbyi C.DC. Leaf CH2Cl2 MCF‑7 (18), H‑460 (13), SF‑268 (16) [16]
Piper sanvicentense Trel. and Yunck. Leaf EtOH 4T1 (24), MDA‑MB‑231 (7) [43]
Piper sarmentosum Roxb. Unknown EtOH HepG2 (12.5) [44]
Root Hexane HeLa (11.6), MCF‑7 (14.4) [41]
Root EtOAc MCF‑7 (9.8) [41]
Piper umbellatum L. Leaf EtOH HeLa (6.71) [36]
*Kava root extract was obtained from Gaia Herbs (Brevard, NC, USA)
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terpenes, steroids, kawapyrones, piperolides, flavonoids, and alke‑
nylphenols.[9,45‑47] Thirty‑two compounds (1‑32) have been reported 
to exhibit cytotoxic activity toward at least one tumor cell line with 
an IC
50
 value less than 4 μg/ml [Table 3]. These compounds include 
amide alkaloids (1‑17), a lignan (18), alkenylphenols (19‑22), chal‑
cones and dihydrochalcones (25‑27), piperolides (28‑31), and other 
chemical classifications. The amide alkaloids account for 53% of 
the total active principles. Chabamide G [13 in Figure 2 and Table 3] 
and sintenpyridone [5 in Figure 2 and Table 3] exhibited the most 
potent activity against human colon adenocarcinoma (COLO‑205; 
IC
50
 = 0.018 μg/ml) and HT‑29 (IC
50
 = 0.025 μg/ml) cell lines, re‑
spectively.[48] Piplartine is the most promising compound showing 
toxicity against dozens of cell lines along with significant in vivo 
activity [Tables 3 and 4].[18,49‑53] 
Table 3. Cytotoxic principles from Piper plants
Compound Plant source Tumor cell line (IC50 μg/ml) Ref.
Piplartine (piperlongumine, 1) Piper aborescens Roxb., Piper 
alatabaccum Trel & Yuncker, 
Piper cenocladum C.DC, 
P. chaba Hunter, P. longum 
L., Piper puberulum Benth, 
P. sylvaticum Roxb., Piper 
tuberculatum Jacq.
A549 (0.60), B‑16 (1.7), CEM (1.4), Daudi 
EBV+ (0.9), DG‑75 EBV‑ (2.7), Hal1G0 (2.2), 
Hal2G1 (1.6), HCT‑8 (0.7), HL‑60 (1.7), 
HT‑29 (0.45), iMycEμ‑1 (2.4), Jukart (1.59), 
K562 (2.04), KB (1.80), Molt‑4 (1.02), Raji 
EBV+ (2.4), Romos EBV‑ (1.4), P‑388 (0.90)
[18,49‑53]
N‑(3‑methoxy‑4,5‑methylenedioxy‑cinnamoy1)‑Δ3‑p
yridin‑2‑one (2)
P. aborescens Roxb. A549 (2.57), HT‑29 (2.15), KB (2.62), 
P‑388 (0.43)
[52]
N‑(3,4‑dimethoxycinnamoyl)‑Δ3‑pyridin‑2‑one (3) P. aborescens Roxb. KB (3.23), P‑388 (0.82) [54]
N‑(3‑methoxy‑4,5‑methylenedioxy‑dihydrocinnamoy
l)‑Δ3‑pyridin‑2‑one (4)
P. aborescens Roxb. HT‑29 (3.80), P‑388 (2.21) [52]
Sintenpyridone (5) Piper sintenense Hatus. A549 (0.89), HT‑29 (0.025), P‑388 (0.121) [55]
Piperine (6) P. nigrum L., P. longum L., 
P. capense L.f.
HeLa (0.27), MCF‑7 (0.28) [21,22]
1‑[(9E)‑10‑(3,4‑methylenedioxy‑phenyl)‑9‑decenoyl] 
pyrrolidine (7)
P. boehmeriifolium HeLa (2.67) [11]
Pipersintenamide (8) P. sintenense Hatus. HL‑60 (3.8), P‑388 (3.78) [55,56]
Sarmentine (9) P. sintenense Hatus. P‑388 (2.81) [55]
Pellitorine (10) P. nigrum L. MCF‑7 (1.8) [41,57]
(2E,4E)‑N‑isobutyl dodecadienamide (11) P. sintenense Hatus. A549 (2.05), HT‑29 (3.36), P‑388 (0.167) [55]
Piplartine dimer A (12) P. aborescens Roxb. A549 (2.21), KB (3.90), HT‑29 (2.49), 
P‑388 (3.06)
[52]
Chabamide G (13) P. chaba Hunter COLO‑205 (0.018) [48]
Chabamide (14) P. chaba Hunter COLO‑205 (3.10) [48]
Cepharadione A (15) Piper caninum Blume, 
P. longum L.
NCI‑H460 (2.5), SF‑268 (2.9) [32,58,59]
Piperolactam A (16) Piper kadsura Ohwi, 
P. longum L.
A549 (2.9), SK‑MEL‑2 (2.2) [31,32]
Piperolactam B (17) P. kadsura Ohwi, P. longum L. SK‑MEL‑2 (3.4) [31,32]
(‑)‑Grandisin (18) Piper solmsianum C.DC. EAT (0.25) [60]
Gibbilimbol D (19) P. gibbilimbum C.DC. KB (2.1) [28]
Gibbilimbol B (20) P. gibbilimbum C.DC. KB (3.9) [28]
4‑Nerolidylcatechol (21) P. umbellatum L. HL‑60 (0.4), KB (1.3) [61,62]
(2’E,6’E)‑2‑farnesylhydroquinone (22) P. barbatum Kunth SF‑268 (1.6) [16]
(2’E,6’E)‑2‑farnesyl‑1,4‑benzo‑quinone (23) P. barbatum Kunth MCF‑7 (1.8), SF‑268 (3.5) [16]
1‑(3,4‑Methlenedioxyphenyl)‑1E‑dodecene (24) P. sintenense Hatus. CCRF‑CEM (1.95), HL‑60 (2.13) [56]
Flavokawain A (25) P. methysticum G. Forst. A2780 (1.32), K562 (2.04) [63]
Flavokawain B (26) P. methysticum G. Forst. 143B (1.97), A2780 (0.56), C4‑2B (2.2), 
DU145 (1.1), K562 (0.95), PC‑3 (1.8), 
SK‑LMS‑1 (1.25)
[40,63‑66]
Piperaduncin A (27) P. aduncum L. KB (2.3) [17]
Cis‑Yangonin (28) P. methysticum G. Forst. A2780 (0.75), K562 (0.42) [63]
Trans‑Yagonin (29) P. methysticum G. Forst. A2780 (2.39), K562 (1.41) [63]
Demethoxyyangonin (30) P. methysticum G. Forst. A2780 (3.77), K562 (2.88) [63]
Kavain (31) P. methysticum G. Forst. A2780 (2.54) [63]
Sintenin (32) P. sintenense Hatus. P388 (0.21) [55]
CEM: Human lymphoblastic leukemia; EBV: Epstein–Barr virus; MCF: Human breast carcinoma
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COMPOUNDS FROM PIPER PLANTS WITH 
ANTITUMOR ACTIVITY IN VIVO
A few Piper (胡椒 Hú Jiāo) compounds have been studied 
for in vivo antitumor activity. Piplartine (1) and flavokawain 
B [26 in Figure 1] exhibited significant inhibitory effects on 
the growth of at least one tumor cell line in vivo at concentra‑
tions less than 15 mg/kg body weight [Table 4]. Piplartine was 
tested against xenograft models of human bladder carcinoma (EJ), 
human breast carcinoma (MDA‑MB436), human alveolar 
carcinoma epithelial (A549), murine melanoma (B16‑F10), 
and MMTV‑polyomavirus middle T antigen transgenic mice 
model (MMTV‑PyVT). Animals were treated for 13 or 21 days 
at a dose of 1.5 or 2.4 mg/kg/day. Marked antitumor effects were 
observed in the treated tumor‑bearing mice with inhibition rates 
near those with positive controls, paclitaxel (10 mg/kg/day) and 
cisplatin (1 mg/kg/day).[67] In addition, flavokawain B treat‑
ment (0.75 mg/kg/day) significantly inhibited in vivo growth of 
human KB cell‑derived tumor xenografts in nude mice.[68]
ANTICANCER MECHANISMS OF ACTION OF 
PIPER COMPOUNDS
Piplartine
Piplartine, also known as piperlongumine, comprises approxi‑
mately 0.11% content in the fruit of P. longum.[18,69] The compound 
kills cancer cells by targeting the stress response to reactive 
oxygen species (ROS). Piplartine induces apoptosis selectively 
in cells that have a cancer genotype by targeting a non‑oncogene 
co‑dependency acquired through expression of the cancer genotype 
in response to transformation‑induced oxidative stress.[67] Struc‑
ture–activity relationships suggest that the electrophilicity of the 
C2‑C3 olefin is critical for the observed effects on cancer cells.[70] 
The latest studies suggest that cancer cell lines are more resilient 
to chemically induced increases in ROS levels than previously 
thought and highlight that electrophilicity may be more closely 
associated with cancer‑selective cell death than ROS elevation.[71]
Piplartine may target p38 signaling to cause selective kill‑
ing of cancer cells and autophagy.[72,73] Research results suggest 
that the anticancer activity of piplartine involves inhibition of 
the ubiquitin‑proteasome system at a pre‑proteasomal step, 
prior to de‑ubiquitination of malfolded protein substrates at the 
proteasome, and that the previously reported induction of ROS is 
a consequence of this inhibition.[74]
Piplartine can down‑regulate Epstein–Barr virus encoded 
latent membrane protein 1 (EBV‑encoded LMP1), cellular my‑
elocytomatosis oncogene (Myc), constitutive nuclear factor kappa 
B (NF‑kB) activity, and a host of LMP1‑Myc‑NF‑kB‑regulated 
target genes, while the LMP1‑NF‑kB‑Myc axis plays the central 
role in B‑lineage neoplasia.[51] Piplartine‑dependent cytotoxicity 
is affected in part by reduced NF‑kB and Myc activity.[50]
Piplartine induces rapid depletion of the androgen receptor 
in prostate cancer cells. Consequently, piplartine may afford 
novel opportunities for both prevention and treatment of prostatic 
malignancy.[75] Piplartine may act, at least in part, on the mito‑
gen‑activated protein kinase (MEK)/extracellular signal‑regulated 
kinase (ERK) pathway to cause colon cancer cell death.[76]
Piperine
Piperine (6) is a major component of black (P. nigrum) and 
long (P. longum) pepper. The content of piperine in black pep‑
per varies between 5% and 9%.[77] Piperine can inhibit human 
fibrosarcoma (HT‑1080) cell expression of matrix metallopro‑
teinase (MMP)‑9, thereby interfering with tumor cell migration 
and invasion.[78] Piperine inhibits HER2 gene expression at the 
transcriptional level implying that it may be a potential agent for 
the prevention and treatment of human breast cancer with HER2 
overexpression.[79] Piperine‑induced cytotoxicity against human 
rectal tumor (HRT)‑18 cells may be mediated at least in part by 
ROS.[80] Piperine also exhibits an antiproliferative effect on human 
prostate cancer cells by inducing cell cycle arrest and autophagy.[81]
Flavokawain B
Kava (Piper methysticum Forst.) is a perennial plant indig‑
enous to the Pacific Islands. Some data indicate that the more kava 
consumed by a population, the lower the cancer incidence in that 
population.[82] Flavokawain B, constituting about 0.015% of kava 
extracts, appears to be a potent antiproliferative agent against a wide 
variety of cancer cells.[83,84] Flavokawain B–induced apoptosis, at 
least in part, requires Bim expression.[66] In KB cells, the induc‑
tion of apoptosis by flavokawain B may involve both the death 
receptor and mitochondrial pathway.[68] Flavokawain B also has a 
pro‑apoptotic effect on synovial sarcomas cell lines.[85] Flavokawain 
B induces apoptosis of non‑small cell lung cancer H‑460 cells via 
Bax‑initiated mitochondrial and c‑Jun N‑terminal kinase (JNK) 
pathways.[86] In osteosarcoma cell lines, apoptotic induction by 
flavokawain B involves both extrinsic and intrinsic pathways. 
Flavokawain B also causes G2/M phase cell cycle arrest.[64]
CONCLUSION
Piper (胡椒 Hú Jiāo) plants are important sources for 
research on and development of new anticancer agents. Ten 
Piper plants have been used as traditional medicines to treat 
cancer or cancer‑like symptoms. In various studies, 35 extracts 
from 24 Piper species and 32 compounds from Piper plants were 
found to possess in vitro cytotoxic activity. Among them, the amide 
alkaloid piplartine (1) represents the most promising candidate 
Table 4. Compounds from Piper plants with antitumor activity in vivo
Compound Tumor Dose 
(mg/kg/
day)
n Days of 
treatment
Route Inhibition 
rate (%)
Ref.
Piplartine 
(1)
EJ 1.5 14 21 i.p. >50 [67]
MDA‑MB436 1.5 14 21 i.p. >50 [67]
A549 1.5 14 21 i.p. >50 [67]
B16‑F10 1.5 14 21 i.p. >50 [67]
MMTV‑PyVT 2.4 12 13 i.p. >50 [67]
Flavokawain 
B (26)
KB 0.75 6 27 i.p. >50 [68]
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showing cytotoxicity against dozens of cell lines, together with 
excellent in vivo activity. Piper plants comprise about 2000 species, 
most of which have not been studied for their chemical constituents 
and anticancer effects. Thus, further in vitro and in vivo anticancer 
research studies on Piper plants and their isolates are worthwhile.
ABBREVIATIONS USED
143B, human osteosarcoma; 4T1, murine mammary carci‑
noma; A549, human alveolar carcinoma epithelial; A2780, human 
ovarian carcinoma; B‑16, murine melanoma; B16‑F10, murine 
melanoma; BCRP, breast cancer resistance protein; C4‑2B, human 
prostate cancer; CCRF‑CEM, human leukemic lymphoblast; CEM, 
human lymphoblastic leukemia; CEM/ADR5000, human acute 
T‑lymphoblastic leukemia; CHCl
3
, chloroform; CH2Cl2, dichlo‑
romethane; COLO‑205, human colon adenocarcinoma; DU‑145, 
human prostate carcinoma; EAT, Ehrlich ascites tumor; EBV, 
Epstein Barr virus; EJ, human bladder carcinoma; ERK, extracel‑
lular signal‑regulated kinase; EtOH, ethanol; MCF‑7, human breast 
carcinoma; H‑460, human large cell lung carcinoma; HCT116 
p53+/+, p53‑expressing human colon cancer cell; HCT116 p53−/−, 
p53‑knockout human colon cancer cell; HeLa, human cervix ad‑
enocarcinoma; HEp‑2, human laryngeal carcinoma; Hep‑G2, hu‑
man hepatocarcinoma; IC
50
, concentration giving 50% inhibition; 
HL‑60, human myeloid leukemia; human promyelocytic leukemia; 
HL‑60AR, anthracycline‑resistant HL‑60; HRT‑18, human rectal 
tumor; HT‑1080, human fibrosarcoma; K562, human erythro‑
myeloblastoid leukemia; KB, human nasopharynx carcinoma; 
LNCaP, human prostate carcinoma; MCF‑7, human breast carci‑
noma; MDA‑MB‑231, human breast carcinoma; MDA‑MB436, 
human breast carcinoma; MEK, mitogen‑activated protein kinase; 
MeOH, methanol; Mia PaCa2, human pancreatic adenocarcinoma; 
MMTV‑PyVT, MMTV‑polyomavirus middle T antigen transgenic 
mice model; Molt‑4, human lymphocytic leukemia; NCI‑H460, 
human non‑small cell lung cancer; NF‑kB, nuclear factor kappa 
B; P‑388, mouse lymphocytic leukemia; PC‑3, human prostate 
adenocarcinoma; PE, petroleum ether; ROS, reactive oxygen 
species; SF‑268, glioma; SK‑LMS‑1, human leiomyosarcoma; 
SK‑MEL‑2, human skin melanoma; U87MG, human malignant 
glioblastoma; U87MGΔEGFR, EGFRvIII expressing glioma cells; 
WPMY‑1, human prostatic stromal myofibroblast.
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